<!DOCTYPE html>
<html  >
<head>
  <!-- Site made with Mobirise Website Builder v5.6.0, https://mobirise.com -->
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Mobirise v5.6.0, mobirise.com">
  <meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1">
  <link rel="shortcut icon" href="assets/images/mbr-121x81.png" type="image/x-icon">
  <meta name="description" content="">
  
  
  <title>Services</title>
  <link rel="stylesheet" href="assets/web/assets/mobirise-icons2/mobirise2.css">
  <link rel="stylesheet" href="assets/web/assets/mobirise-icons-bold/mobirise-icons-bold.css">
  <link rel="stylesheet" href="assets/bootstrap/css/bootstrap.min.css">
  <link rel="stylesheet" href="assets/bootstrap/css/bootstrap-grid.min.css">
  <link rel="stylesheet" href="assets/bootstrap/css/bootstrap-reboot.min.css">
  <link rel="stylesheet" href="assets/parallax/jarallax.css">
  <link rel="stylesheet" href="assets/web/assets/gdpr-plugin/gdpr-styles.css">
  <link rel="stylesheet" href="assets/dropdown/css/style.css">
  <link rel="stylesheet" href="assets/socicon/css/styles.css">
  <link rel="stylesheet" href="assets/theme/css/style.css">
  <link rel="preload" href="https://fonts.googleapis.com/css?family=Jost:100,200,300,400,500,600,700,800,900,100i,200i,300i,400i,500i,600i,700i,800i,900i&display=swap" as="style" onload="this.onload=null;this.rel='stylesheet'">
  <noscript><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Jost:100,200,300,400,500,600,700,800,900,100i,200i,300i,400i,500i,600i,700i,800i,900i&display=swap"></noscript>
  <link rel="preload" href="https://fonts.googleapis.com/css?family=Lato:100,100i,300,300i,400,400i,700,700i,900,900i&display=swap" as="style" onload="this.onload=null;this.rel='stylesheet'">
  <noscript><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Lato:100,100i,300,300i,400,400i,700,700i,900,900i&display=swap"></noscript>
  <link rel="preload" as="style" href="assets/mobirise/css/mbr-additional.css"><link rel="stylesheet" href="assets/mobirise/css/mbr-additional.css" type="text/css">
  
  
  
  
</head>
<body>
  
  <section data-bs-version="5.1" class="menu menu2 cid-sFCw1qGFAI" once="menu" id="menu2-23">
    
    <nav class="navbar navbar-dropdown navbar-expand-lg">
        <div class="container">
            <div class="navbar-brand">
                
                <span class="navbar-caption-wrap"><a class="navbar-caption text-info text-primary display-5" href="index.html">PTOPENSCREEN</a></span>
            </div>
            <button class="navbar-toggler" type="button" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbarSupportedContent" data-bs-target="#navbarSupportedContent" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation">
                <div class="hamburger">
                    <span></span>
                    <span></span>
                    <span></span>
                    <span></span>
                </div>
            </button>
            <div class="collapse navbar-collapse" id="navbarSupportedContent">
                <ul class="navbar-nav nav-dropdown nav-right" data-app-modern-menu="true"><li class="nav-item"><a class="nav-link link text-black text-primary display-4" href="index.html">Home</a></li>
                    
                    <li class="nav-item"><a class="nav-link link text-black text-primary display-4" href="index.html#form5-s">Contacts</a></li></ul>
                
                
            </div>
        </div>
    </nav>
</section>

<section data-bs-version="5.1" class="header1 cid-sWR506y31c" id="header1-y">

    

    <div class="mbr-overlay" style="opacity: 0.6; background-color: rgb(255, 255, 255);"></div>

    <div class="align-center container">
        <div class="row justify-content-center">
            <div class="col-12 col-lg-9">
                <h1 class="mbr-section-title mbr-fonts-style mb-3 display-2"><strong>Services</strong></h1>
                
                <p class="mbr-text mbr-fonts-style display-7">Working with different partners institutions, PTOPENSCREEN offers a collection of services.&nbsp;<br>For service or information requests, please fill the <a href="index.html#form5-s" class="text-primary">contact form</a>&nbsp;and your request will be relayed to a suitable partner of the network.<br>
<br>
<br><br></p>
                
            </div>
        </div>
    </div>
</section>

<section data-bs-version="5.1" class="features1 cid-sFzyUE9AaP" id="features1-1i">
    

    
    <div class="container-fluid">
        <div class="row">
            
        </div>
        <div class="row">
            <div class="card col-12 col-md-6 col-lg-3">
                <div class="card-wrapper">
                    <div class="card-box align-center">
                        <div class="iconfont-wrapper">
                            <span class="mbr-iconfont mbrib-bold"></span>
                        </div>
                        <h5 class="card-title mbr-fonts-style display-5"><a href="services.html#slider5-z" class="text-primary">Biology</a></h5>
                        <p class="card-text mbr-fonts-style display-7">From standard assays to the development of new assays and analysis of the results</p>
                    </div>
                </div>
            </div>
            <div class="card col-12 col-md-6 col-lg-3">
                <div class="card-wrapper">
                    <div class="card-box align-center">
                        <div class="iconfont-wrapper">
                            <span class="mbr-iconfont socicon-quora socicon"></span>
                        </div>
                        <h5 class="card-title mbr-fonts-style display-5"><a href="services.html#slider5-11" class="text-primary">Chemistry</a></h5>
                        <p class="card-text mbr-fonts-style display-7">Compound bioprofiling of small molecule libraries on the panel of cell lines and data analysis.</p>
                    </div>
                </div>
            </div>
            <div class="card col-12 col-md-6 col-lg-3">
                <div class="card-wrapper">
                    <div class="card-box align-center">
                        <div class="iconfont-wrapper">
                            <span class="mbr-iconfont mobi-mbri-contact-form mobi-mbri"></span>
                        </div>
                        <h5 class="card-title mbr-fonts-style display-5"><strong><a href="services.html#slider5-10" class="text-primary">Consultancy&nbsp;&amp; Analysis</a></strong></h5>
                        <p class="card-text mbr-fonts-style display-7">The management and execution of projects,&nbsp;Identification of suitable experimental approach.</p>
                    </div>
                </div>
            </div>
            
        </div>
    </div>
</section>

<section data-bs-version="5.1" class="features7 cid-sX1KQuQUK4 mbr-parallax-background" id="features8-1e">
    <!---->
    
    <div class="mbr-overlay" style="opacity: 0.5; background-color: rgb(255, 255, 255);">
    </div>
    <div class="container">
        <div class="row">
            <div class="title col-12">
                
                
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Assay miniaturization</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-5"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">
                            Adaptation of cell or biochemical assays to microwell plate format for screening to achieve robust and reproducible readouts with minimum intra and inter-plate variability.<br><br>CBMA, CBA-UAC, CEB-UM, CEDOC, CIEQB, CNC, CQM, ToxOmics, CIIMAR, iBiMED, BioISI, ICVS, IHMT, iMED.Ulisboa, iMM, i3S<br>
                        </p>
                    </div>
                </div>
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Compound profiling</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-5"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">
                            Original small molecules or extracts from natural sources are profiled using different cellular models, including human cells from healthy and diseased-altered tissues. Assays to collect information about viability will suggest compounds with a promising therapeutic profile for follow-up experiments.<br><br>CBMA, CBA-UAC, CEDOC, CIEQB, CNC, CQM, ToxOmics, CIIMAR, iBiMED, BioISI, ICVS, IHMT, iMED.Ulisboa, iMM, i3S<br>
                        </p>
                    </div>
                </div>
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Pilot screening</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-5"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">
                            Screening of compound libraries of up to 5000 compounds as final job or as preparation to full screening campaigns of more than 100000 compounds. Includes hit confirmation and validation and may include follow-up studies.<br><br>CBMA, CBA-UAC, CEB-UM, CEDOC, CIEQB, CNC, CQM, ToxOmics, CIIMAR, iBiMED, BioISI, ICVS, IHMT, iMED.Ulisboa, iMM, i3S<br>
                        </p>
                    </div>
                </div>
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>High-Throughput screening</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-5"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">
                            Screening of compound libraries more than 100000 compounds. Includes hit confirmation and validation and may include follow-up studies.<br><br>i3S<br>
                        </p>
                    </div>
                </div>
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Target deconvolution&nbsp;</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-5"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">
                            Cell and/or biochemical assays are designed and performed for target deconvolution of hits resulting from phenotypical-based screenings.<br><br>CBMA, CBA-UAC, CEB-UM, CEDOC, CIEQB, CNC, CQM, ToxOmics, CIIMAR, iBiMED, BioISI, ICVS, IHMT, iMED.Ulisboa, iMM, i3S<br></p>
                    </div>
                </div>
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Drug-target interactions</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-5"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">Bio-Layer Interferometry is used to perform label-free, real-time study of biomolecular interactions (drug-receptor, protein-protein interactions) for determination of binding constants and kinetics.<br><br>CEB-UM<br></p>
                    </div>
                </div>
            </div>
            
            
            
            
            
            
        </div>
    </div>
</section>

<section data-bs-version="5.1" class="features7 cid-sX1Nvmqn7I mbr-parallax-background" id="features8-1g">
    <!---->
    
    <div class="mbr-overlay" style="opacity: 0.5; background-color: rgb(255, 255, 255);">
    </div>
    <div class="container">
        <div class="row">
            <div class="title col-12">
                
                
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Evaluation of drug-like properties</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-5"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">
                            Evaluation of physicochemical properties (e.g. solubility, lipophilicity (LogD / LogP), pKa) that can affect biological assay results and cause incorrect structure-activity relationships. This evaluation is relevant in early drug discovery programs and necessary for ADMET studies.<br><br>CIQUP, CQM, CQUM, CQC, iMED.Ulisboa, CQE<br>
                        </p>
                    </div>
                </div>
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Hit to lead or lead optimization</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-5"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">
                            For newly identified compounds with targeted biological activity (hits), optimization performed by medicinal chemistry tools is offered in order to obtain pharmacologically viable advanced candidates possessing optimized activity/potency/selectivity profiles and/or chemical novelty.<br><br>CIQUP, CQM, CQUM, CQC, iMED.Ulisboa, CQE<br>
                        </p>
                    </div>
                </div>
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Custom synthesis</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-7"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">
                            Synthesis of different chemical tools such as building blocks, standards for pharmacological and analytical purposes, degradation products or impurities, human metabolites or prodrugs to improve pharmacokinetic properties, in small to medium sized libraries.<br><br>CIQUP, CQM, CQUM, CQC, iMED.Ulisboa, CQE<br>
                        </p>
                    </div>
                </div>
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Evaluation of drug or drug candidate stability</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-5"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">The evaluation of compound storage stability (in solution or solid state) and compound metabolic stability (namely in plasma and in hepatocytes) can be performed using chromatographic (UHPLC/HPLC) and spectrometric (NMR/MS) tools.<br>&nbsp;<br>CIQUP, CQM, CQUM, CQC, iMED.Ulisboa, CQE, IMM, BioISI<br>
                        </p>
                    </div>
                </div>
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Evaluation of drug or drug candidate permeability using biomimetic membrane models&nbsp;</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-7"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">
                            BBB, gastro-intestinal and skin permeability prediction can be attained using non-cellular (Parallel Artificial Membrane Permeability Assay) permeability assays. If needed, permeability studies using cellular assays like Caco-2 cells, can be performed.<br><br>CIQUP, CQM, CQC, iMED.Ulisboa, CQE, IMM<br></p>
                    </div>
                </div>
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Quality control of compounds</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-5"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">The consortium has the necessary equipment to perform quality control of libraries of compounds and isolation/ purification of samples. The consortium also has equipment for chemical characterization (NMR, HPLC-MS).<br><br>CIQUP, CQM, CQUM, CQC, iMED.Ulisboa, CQE, BioISI<br></p>
                    </div>
                </div>
            </div>
            
            
            
            
            
            
        </div>
    </div>
</section>

<section data-bs-version="5.1" class="features7 cid-sX1SrjFkPq mbr-parallax-background" id="features8-1h">
    <!---->
    
    <div class="mbr-overlay" style="opacity: 0.5; background-color: rgb(255, 255, 255);">
    </div>
    <div class="container">
        <div class="row">
            <div class="title col-12">
                
                
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Construction of chemical libraries</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-7"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">
                            Synthesis of small focused libraries for screening based on target or compound class, isolation of novel compounds from biological extracts (different chromatographic techniques) and characterization of new structures (NMR, HPLC-MS).<br><br>CIQUP, CQM, CQUM, CQC, iMED.Ulisboa, CQE, CIIMAR<br>
                        </p>
                    </div>
                </div>
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Access to compound libraries</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-5"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">
                            Chemical banking for management and storage will provide access to libraries of bioactive, target-focused or diversity-based compounds, fragments, biological extracts, to compounds produced by Portuguese chemists and, as part of the EU-OPENSCREEN, to the European Chemical Biology Library.<br><br>i3S, CBMA, CBA-UAC, CEB-UM, CEDOC, CIEQB, CNC, CQM, ToxOmics, CIIMAR, iBiMED, BioISI, ICVS, IHMT, iMED.Ulisboa, iMM<br>
                        </p>
                    </div>
                </div>
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Access to libraries of tools for genome-wide gene perturbation</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-7"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">
                            Libraries of siRNAs, microRNAs, dsRNAs (C.elegans), CRISPR (guide RNA) and yeast mutants allow the identification of disease-relevant target genes that could be further used as basis for the development of target-based chemical screens.<br><br>CNC, ICVS, BioISI, CBMA, i3S<br>
                        </p>
                    </div>
                </div>
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Access to readout instruments</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-7"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">
                            Access to microplate readers (absorbance, fluorescence, luminescence and related technologies) and automated widefield and confocal microscopes (high-content assays).<br><br>CBMA, CBA-UAC, CEB-UM, CEDOC, CIEQB, CNC, CQM, ToxOmics, CIIMAR, iBiMED, BioISI, ICVS, IHMT, iMED.Ulisboa, iMM, i3S<br>
                        </p>
                    </div>
                </div>
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Medicinal Chemistry projects and consulting</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-7"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">
                            The consortium has experience in the management and execution of projects of preclinical Medicinal Chemistry. The consortium offers both consultancy in project management and design, synthesis of dedicated libraries and characterization of new structures (NMR, HPLC-MS).<br><br>CIQUP, CQM, CQUM, CQC, iMED.Ulisboa, CQE, BioISI<br>
                        </p>
                    </div>
                </div>
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Consultancy on experimental screening strategy</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-7"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">
                            Identification of suitable experimental approach: cell or biochemical assay, chemical libraries size and composition, selection of suitable material and reagents, readout technology such as absorbance, fluorescence intensity, luminescence, high-content screening on automated fluorescence microscope.<br><br>CBMA, CBA-UAC, CEB-UM, CEDOC, CIEQB, CIQUP, CNC, CQM, CQUM, CQC, CQE, ToxOmics, CIIMAR, iBiMED, BioISI, ICVS, IHMT, iMED.Ulisboa, iMM, i3S<br>
                        </p>
                    </div>
                </div>
            </div>
            
            
            
            
            
            
        </div>
    </div>
</section>

<section data-bs-version="5.1" class="features7 cid-sX1UhaSt5X" id="features8-1i">
    <!---->
    
    
    <div class="container">
        <div class="row">
            <div class="title col-12">
                
                
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Bioimage analysis</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-5"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">
                            Automated processing of microscopy images (fluorescence or transmission) using appropriate software tools and IT infrastructure to extract quantitative phenotypic data in numerical form. Extraction of multi-parametric quantitative features at the single cell level for high content screening assays.<br><br>CEDOC, CNC, BioISI, ICVS, iMM, i3S, iBiMED<br>
                        </p>
                    </div>
                </div>
            </div>
            <div class="card col-12 col-md-6">
                <div class="card-wrapper">
                    <div class="top-line">
                        <h6 class="card-title mbr-fonts-style display-5"><strong>Statistical data analysis</strong></h6>
                        <p class="mbr-text cost mbr-fonts-style display-5"></p>
                    </div>
                    <div class="bottom-line">
                        <p class="mbr-text mbr-fonts-style display-7">
                            Efficient analysis of large numerical datasets produced by spectroscopy or image-based screening using data science tools to report the phenotypic variation caused by each chemical perturbation. Will include data visualization, exploratory data analysis, quality control and normalization.<br><br>CNC, ICVS, BioISI, iMM, i3S<br>
                        </p>
                    </div>
                </div>
            </div>
            
            
            
            
            
            
            
            
            
            
        </div>
    </div>
</section>

<section data-bs-version="5.1" class="contacts4 cid-sFAyMcKwph" id="contacts4-21">

    

    

    <div class="container">
        <div class="row align-items-center justify-content-center">
            <div class="text-content col-12 col-md-6">
                <h2 class="mbr-section-title mbr-fonts-style display-2">
                    <strong>Follow Us</strong>
                </h2>
                <p class="mbr-text mbr-fonts-style display-7">Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc ut dapibus massa, efficitur varius augue. In vel elit lorem. Fusce et dui fringilla, suscipit nulla sed, viverra nunc. Nulla ut justo ut enim vehicula maximus. Nam et neque tempus, ultricies purus vel, suscipit leo. Praesent orci turpis, maximus facilisis rhoncus vel, consequat ac augue. Nam facilisis mi non elit tempor sodales.<br></p>
            </div>
            <div class="icons d-flex align-items-center col-12 col-md-6 justify-content-end mt-md-0 mt-2 flex-wrap">
                <a href="https://twitter.com/mobirise" target="_blank">
                    <span class="socicon-twitter socicon mbr-iconfont mbr-iconfont-social"></span>
                </a>
                <a href="https://www.facebook.com/pages/Mobirise/1616226671953247" target="_blank">
                    <span class="socicon-facebook socicon mbr-iconfont mbr-iconfont-social"></span>
                </a>
                <a href="https://www.youtube.com/c/mobirise" target="_blank">
                    <span class="socicon-youtube socicon mbr-iconfont mbr-iconfont-social"></span>
                </a>
                <a href="https://instagram.com/mobirise" target="_blank">
                    <span class="socicon-instagram socicon mbr-iconfont mbr-iconfont-social"></span>
                </a>
                
                
                
                
                
                
            </div>
        </div>
    </div>
    
</section>

<section data-bs-version="5.1" class="footer7 cid-sWRgqS5SQe" once="footers" id="footer7-14">

    

    

    <div class="container">
        <div class="media-container-row align-center mbr-white">
            <div class="col-12">
                <p class="mbr-text mb-0 mbr-fonts-style display-7">
                    © Copyright 2025 Mobirise - All Rights Reserved
                </p>
            </div>
        </div>
    </div>
</section><section style="background-color: #fff; font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', 'Roboto', 'Helvetica Neue', Arial, sans-serif; color:#aaa; font-size:12px; padding: 0; align-items: center; display: flex;"><a href="https://mobirise.site/o" style="flex: 1 1; height: 3rem; padding-left: 1rem;"></a><p style="flex: 0 0 auto; margin:0; padding-right:1rem;">Created with <a href="https://mobirise.site/b" style="color:#aaa;">Mobirise</a> template</p></section><script src="assets/bootstrap/js/bootstrap.bundle.min.js"></script>  <script src="assets/parallax/jarallax.js"></script>  <script src="assets/web/assets/cookies-alert-plugin/cookies-alert-core.js"></script>  <script src="assets/web/assets/cookies-alert-plugin/cookies-alert-script.js"></script>  <script src="assets/smoothscroll/smooth-scroll.js"></script>  <script src="assets/ytplayer/index.js"></script>  <script src="assets/dropdown/js/navbar-dropdown.js"></script>  <script src="assets/sociallikes/social-likes.js"></script>  <script src="assets/theme/js/script.js"></script>  
  
  
<div id="cookie-dialog" style="display: none;"><div id="cookiesdirective"><div style="position: fixed; top: 0; right: 0; bottom: 0; left: 0; background-color: rgb(0, 0, 0); opacity: 0.8; z-index: 9999;"></div><div style="position: fixed; top: 0; right: 0; bottom: 0; left: 0; display: flex; align-items: center; z-index: 10000"><div class="cookie-wrapper" style="position: relative; width: 100%; max-width: 500px; margin-right: auto; margin-left: auto; padding: 1rem; text-align: center; border-radius: .3rem; box-shadow: 0 10px 40px 0 rgba(0,0,0,0.2); color:#424a4d; background:rgba(234, 239, 241, 0.99);"><div class="mbr-text"><p class="display-7">We use cookies to give you the best experience. Read our <a style='color: #424a4d; text-decoration: underline;' href='privacy.html'>cookie policy</a>.</p></div><div class="mbr-section-btn"><a style="margin:0;;" class="btn btn-sm btn-primary display-7" id="impliedsubmit">Agree</a></div></div></div></div></div>
  <input name="cookieData" type="hidden" data-cookie-customDialogSelector='#cookie-dialog' data-cookie-colorText='#424a4d' data-cookie-colorBg='rgba(234, 239, 241, 0.99)' data-cookie-textButton='Agree' data-cookie-colorButton='' data-cookie-colorLink='#424a4d' data-cookie-underlineLink='true' data-cookie-text="We use cookies to give you the best experience. Read our <a href='privacy.html'>cookie policy</a>.">
  </body>
</html>